MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-AP-10-0002981
Synnat Pharma Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹71.34 Cr
▲ 12% YoY
Net profit · FY 2024
₹14.85 Cr
Net margin 20.8%
EBITDA · FY 2024
₹23.61 Cr
EBITDA margin 33.1%
Authorised capital
₹3 Cr
Registered with MCA
Paid-up capital
₹6.6 Lakh
Issued & subscribed
Open charges
₹25 Cr
Secured borrowings
Company age
15 yrs
Est. 2011
Employees · EPFO
189
Provident fund records
About Synnat Pharma Private Limited
Data last updated:
Synnat Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 31 May 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2011PTC074746. Its GSTIN is 36AAPCS8980F1ZN (Telangana). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹6.6 Lakh. It is led by directors including Siddharth Karnani and Ramesh Kumar Karnani.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2024, the company reported a revenue of ₹71.34 Cr, a growth of 12% compared to the previous year. For the same year it recorded a net profit of ₹14.85 Cr (net margin 20.8%) and EBITDA of ₹23.61 Cr (EBITDA margin 33.1%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years and 33% over five years.
The company has about 189 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Synnat Pharma. As per MCA filings, the company has open charges of ₹25 Cr on record. Court records list 1 case involving the company, including 1 filed by the company. The company has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹4 Lakh; the latest was in January 2023. Its 10 peer companies in the Pharma industry (Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Abhiflax Pharma-Chem Private Limited with revenue of ₹72.42 Cr.
Synnat Pharma Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-AP-10-0002981). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website synnatpharma.com.
Company Details of Synnat Pharma Private Limited
CIN U24232TG2011PTC074746
Registration Number 074746
Incorporation Date 31 May 2011
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-AP-10-0002981
CIN History of Synnat Pharma Private Limited
Synnat Pharma has one previous CIN (Corporate Identification Number): U24232AP2011PTC074746. The current CIN is U24232TG2011PTC074746, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2011PTC074746 | Current |
| U24232AP2011PTC074746 | Previous |
Recognitions & Rankings of Synnat Pharma
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address3rd Floor Tower – 2 (Eastern Side), Vamsirams Jyothi Granules Kondapur, Hyderabad, Telangana, India – 500084
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Synnat Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Synnat Pharma Private Limited
Synnat Pharma operates one associated brand: Synnat Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures active pharmaceutical ingredients and intermediates for global markets. | synnatpharma.com |
Business Activity of Synnat Pharma Private Limited
The main business activity of Synnat Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Synnat Pharma Private Limited FY 2024 filings available
Synnat Pharma Private Limited reported revenue of ₹71.34 Cr (up 12% YoY) for FY 2024.
Revenue · FY 2024
₹71.34 Cr ▲ 12%
Net profit · FY 2024
₹14.85 Cr margin 20.8%
EBITDA · FY 2024
₹23.61 Cr margin 33.1%
Compounded Annual Growth Rate (CAGR) of Synnat Pharma Private Limited
Revenue CAGR growth
1 year
▲ 12%
3 years · compounded
▲ 15%
5 years · compounded
▲ 33%
EBITDA CAGR growth
1 year
▲ 22%
3 years · compounded
▲ 32%
5 years · compounded
▲ 71%
Revenue has grown at a compounded annual rate (CAGR) of 33% over five years, including 12% growth in the latest year. EBITDA rose 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Synnat Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹23.61 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹14.85 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Synnat Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 33.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 20.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Synnat Pharma are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Synnat Pharma Private Limited
Synnat Pharma has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Siddharth Karnani | Director | 03 Dec 2022 | 3 Years 10 Months | Current |
| Ramesh Kumar Karnani | Director | 31 May 2011 | 15 Years 4 Months | Current |
| Karnani Ritesh | Director | 03 Dec 2022 | 3 Years 10 Months | Current |
Peer Comparison of Synnat Pharma Private Limited
Synnat Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Abhiflax Pharma-Chem Private Limited | ₹72.42 Cr (FY 2024) | •••• | •••• | -4.0% | •••• | Mumbai, Maharashtra, India |
| Vance and Health Pharmaceuticals Private Limited | ₹72.08 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | Hyderabad, Telangana, India |
| Walpar Nutritions Limited Listed | ₹72.03 Cr (FY 2025) | •••• | •••• | 15.0% | •••• | Gandhinagar, Gujarat, India |
| Nucrest Pharma Private Limited | ₹71.97 Cr (FY 2025) | •••• | •••• | 21.0% | •••• | Mumbai, Maharashtra, India |
| Momentum Biotech Private Limited | ₹71.34 Cr (FY 2025) | •••• | •••• | 147.0% | •••• | Jaipur, Rajasthan, India |
| Synnat Pharma Private Limited this company | ₹71.34 Cr (FY 2024) | •••• | •••• | 12.0% | •••• | Hyderabad, Telangana, India |
| Sanjivani Paranteral Limited Listed | ₹71.31 Cr (FY 2025) | •••• | •••• | 30.0% | •••• | Mumbai, Maharashtra, India |
| Geeta Laboratories Private Limited | ₹71.23 Cr (FY 2024) | •••• | •••• | -6.0% | •••• | Mumbai, Maharashtra, India |
| Simpex Pharma Private Limited | ₹70.72 Cr (FY 2025) | •••• | •••• | 24.0% | •••• | New Delhi, Delhi, India |
| Global Pharma Healthcare Private Limited | ₹70.65 Cr (FY 2025) | •••• | •••• | -9.0% | •••• | Chennai, Tamil Nadu, India |
| Jaahnavee Lifesciences Private Limited | ₹70.16 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Synnat Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Synnat Pharma Private Limited
Synnat Pharma Private Limited is audited by AGARWAL MAHESWARI & CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| AGARWAL MAHESWARI & CO | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Synnat Pharma Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Synnat Pharma Private Limited
Open charges
₹25 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Aug 2025 | Others | ₹10 Cr | Open |
| 30 Aug 2025 | Others | ₹15 Cr | Open |
Total charge records: 2 View all charges
Deals & Funding of Synnat Pharma Private Limited
Synnat Pharma Private Limited has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹4 Lakh; the latest was in January 2023.
Total deals
3
Secondary share transfers
2
Funding round
1
Disclosed funding
₹4 Lakh
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jan 2023 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: an individual |
| Sep 2013 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Jan 2012 | Funding round | ₹4 Lakh | Investors: 4 individuals |
Premium access
Full deal history
All 3 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Synnat Pharma Private Limited
Synnat Pharma Private Limited has 1 court case on record: 1 filed by Synnat Pharma. All case is disposed.
Total cases
1
Filed by the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, ANDHRAPRADESH | Writ petition | Filed by the company against Eastern Power Distribution Company of Andhra Pradesh Ltd., and 1 other | Disposed |
Premium access
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Synnat Pharma Private Limited
Synnat Pharma Private Limited has a workforce of 189 employees as of Mar 29, 2024.
Employee count
189
Active EPFO establishments
1
Employee growth
35.97%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Synnat Pharma Private Limited
Synnat Pharma Private Limited has 6 board changes on record since 2011: 3 appointments and 3 cessations. The latest: Sohan Lall Karnani ceased to be Director on 20 Feb 2023.
Charges
A charge with Others amounted to Rs. 10.00 Cr with Charge ID 101166436 was registered on 30 Aug 2025.
Charges
A charge with Others amounted to Rs. 15.00 Cr with Charge ID 101166435 was registered on 30 Aug 2025.
AGM
Synnat Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Synnat Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Ceased
Sohan Lall Karnani ceased to be Director.
Appointed
Karnani Ritesh was appointed as Director.
Ceased
Karnani Ritesh ceased to be Additional Director.
Appointed
Siddharth Karnani was appointed as Director.
Ceased
Siddharth Karnani ceased to be Additional Director.
Appointed
Ramesh Kumar Karnani was appointed as Director.
Incorporation
31 May 2011
Synnat Pharma Private Limited was registered on 31 May 2011 with Roc Hyderabad & aged 15 years 4 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Synnat Pharma Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Synnat Pharma Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Synnat Pharma Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Synnat Pharma Private Limited
Synnat Pharma has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAPCS8980F1ZN | Telangana | Active | 11 Jan 2025 |
| 37AAPCS8980F1ZL | Andhra Pradesh | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Synnat Pharma Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Synnat Pharma Private Limited
Synnat Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 31 May 2011 (15+ years old) and is registered under CIN U24232TG2011PTC074746.
Synnat Pharma reported revenue of ₹71.34 Cr for FY 2024 (up 12% YoY).
Synnat Pharma has 3 current directors:
- Siddharth Karnani - Director
- Ramesh Kumar Karnani - Director
- Karnani Ritesh - Director
Synnat Pharma reported a net profit of ₹14.85 Cr (net margin 20.8%) and EBITDA of ₹23.61 Cr (EBITDA margin 33.1%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Synnat Pharma is 15% over three years and 33% over five years. In the latest year (FY 2024) revenue rose 12%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Synnat Pharma is 36AAPCS8980F1ZN, registered in Telangana. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 37AAPCS8980F1ZL (Andhra Pradesh).
The CIN (Corporate Identification Number) of Synnat Pharma is U24232TG2011PTC074746. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Synnat Pharma has 1 court case on record: 1 filed by the company.
Synnat Pharma was incorporated on 31 May 2011, making it 15+ years old. It is registered with the Registrar of Companies, Hyderabad.
Synnat Pharma has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹4 Lakh; the latest was in January 2023.
The peers of Synnat Pharma by revenue are Abhiflax Pharma-Chem Private Limited, Vance and Health Pharmaceuticals Private Limited, Walpar Nutritions Limited, Nucrest Pharma Private Limited, Momentum Biotech Private Limited and 5 more, all in the Pharma industry (Formulations).